Monoclonal antibody directed against BCR-ABL oncoprotein.
| Inventor | Institute |
|---|---|
| Susheela Dhut | Queen Mary University of London |
| Cat. #: | 151062 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cancer;Cell signaling and signal transduction;Genetics |
| Application: | IF ; IP ; WB |
| Target: | BCRABL |
| Reactivity: | Human |
| Clone: | 7c6 |
| Host: | Mouse |
| Class: | Monoclonal |
| Alternate name: | Cell division control protein 13; YDL22C |
|---|---|
| Product description: | Monoclonal antibody directed against BCR-ABL oncoprotein. |
| Conjugation: | Unconjugated |
| Isotype: | IgG2a |
| Molecular weight: | 210 kDa |
| Immunogen: | Bcr686 thyroglobulin conjugate |
| Immunogen Uniprot ID: | Q62199 |
| Myeloma used: | P3X63Ag8 |
| Target background: | The BCR gene is involved in the 9:22 translocation that generates the Philadelphia chromosome both in chronic myeloid leukaemia (CML) and in a proportion of cases of acute lymphocytic leukaemia (ALL). A 5' bcr sequence becomes fused to an abl sequence (including tyrosine kinase domain sequences) from chromosome 9. This results in the production of a chimeric BCR-ABL oncoprotein with constitutively active tyrosine kinase activity. Anti-BCRABL antibody may be useful for studies of the oncogene and have potential diagnostic and prognostic applications, particularly within leukaemia. This antibody is specific for the SSINEEITPRRQS epitope of BCR (residues 686-696), and as such is able to recognise full-length BCR and the p210 form of the BCR-ABL fusion protein. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | Store at -20° C frozen. Avoid repeated freeze / thaw cycles |
| Shipping conditions: | Dry ice |
| References: |
Mallery et al. 2017. Cancer Prev Res (Phila). 10(1):76-88. PMID: 27756753. Dhut et al. 1990. Leukemia. 4(11):745-50. PMID: 2232885. BCR-ABL and BCR proteins: biochemical characterization and localization. Dhut et al. 1988. Oncogene. 3(5):561-6. PMID: 3078961. Identification of two normal bcr gene products in the cytoplasm. Walker et al. 1987. Nature. 329(6142):851-3. PMID: 3478595. Novel chimaeric protein expressed in Philadelphia positive acute lymphoblastic leukaemia. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151030 | Anti-Progesterone [11P14] |
Key Info
Anti-Progesterone [11P14]
|
View Tool | |||||||||||||||||||
| 151015 | Anti-CyclinA [E70.1] |
Key Info
Anti-CyclinA [E70.1]
|
View Tool | |||||||||||||||||||
| 151029 | Anti-HSVICP8 [11E2] |
Key Info
Anti-HSVICP8 [11E2]
|
View Tool | |||||||||||||||||||
| 151031 | Anti-RuvA [RuvA 12C6] |
Key Info
Anti-RuvA [RuvA 12C6]
|
View Tool | |||||||||||||||||||
| 151020 | Anti-CyclinB1 [V143.1] |
Key Info
Anti-CyclinB1 [V143.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.